Update on the therapy of Behçet disease

103Citations
Citations of this article
149Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Behçet disease is a chronic inflammatory systemic disorder, characterized by a relapsing and remitting course. It manifests with oral and genital ulcerations, skin lesions, uveitis, and vascular, central nervous system and gastrointestinal involvement. The main histopathological finding is a widespread vasculitis of the arteries and veins of any size. The cause of this disease is presumed to be multifactorial involving infectious triggers, genetic predisposition, and dysregulation of the immune system. As the clinical expression of Behçet disease is heterogeneous, pharmacological therapy is variable and depends largely on the severity of the disease and organ involvement. Treatment of Behçet disease continues to be based largely on anecdotal case reports, case series, and a few randomized clinical trials. © 2014, SAGE Publications. All rights reserved.

Cite

CITATION STYLE

APA

Saleh, Z., & Arayssi, T. (2014). Update on the therapy of Behçet disease. Therapeutic Advances in Chronic Disease. https://doi.org/10.1177/2040622314523062

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free